Positive Results In Phase 3 Trial Of Covid Pill, Says Hyderabad-Based Hetero Pharma Group

Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.

Related Keywords

Hyderabad ,Andhra Pradesh ,India ,Movfor Molnupiravir ,Hetero Pharma Group Under The Phase ,Positive Results In Phase ,Covid Pill ,Says Hetero Pharma Group ,Oral Abstract ,Opportunistic Infections ,Covid Antiviral Treatments ,Hetero Pharmaceutical Group ,Movfor ,Molnupiravir ,